When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SBBP - Strongbridge Biopharma's Recorlev successful in Cushing's syndrome study
Strongbridge Biopharma plc
Strongbridge Biopharma (NASDAQ:SBBP)announces positive results from a 44-subject Phase 3 clinical trial, LOGICS, evaluating Recorlev (levoketoconazole) in patients with endogenous Cushing's syndrome, a metabolic disorder characterized by the excess production of the hormone cortisol.
More news on: Strongbridge Biopharma plc, Healthcare stocks news, Stocks on the move,